Chinese scientists modify gene to make humans immune to HIV

"In this study, we demonstrated that the HIV—resistant mutation could be introduced into early human embryos through the CRISPR system," said Fan Yong, a researcher.

April 22, 2016 07:29 pm | Updated December 01, 2018 12:24 pm IST - Beijing

In a breakthrough in the fight against HIV/AIDS, Chinese scientists have modified a gene in embryos in an attempt to make humans immune to the HIV virus.

Researchers from the Guangzhou Medical University used a gene editing technique named CRISPR/Cas to replace the CCR5 gene in 26 human embryos with an HIV—resistant mutation. Only four embryos were successfully edited, while the other 22 cases failed to produce the desired results.

The research was published in the Journal of Assisted Reproduction and Genetics.

“In this study, we demonstrated that the HIV—resistant mutation could be introduced into early human embryos through the CRISPR system,” said Fan Yong, a researcher of the Guangzhou Medical University and an author of the paper was quoted as saying by state-run China Daily .

The CRISPR/Cas9 gene editing technique, better known as the molecular Swiss army knife, is a technology developed by U.S. scientist Jennifer Doudna and French scientist Emmanuelle Charpentier in 2012.

 

Since then, scientists from across the globe have been using the technology to edit animals’ gene in the laboratory.

Huang Junjiu, a biologist at Sun Yat-Sen University in Guangzhou, was the first to apply the technique to humans. He reported his experiment on 71 human embryos in Nature magazine in April 2015.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.